If we even put the vaccine work aside and I know what Rjs said, forget about the MSO also, the Excellagen should be a revenue generating cow for Generex and there should not be a debate there. They said they have an order already for it and they have another coming also. So, what bothers me is we haven't heard a peep about Excellagen and what is going on, since the note in the 10-Q, The first batch, while not huge, should still matter and then the next one is bigger I think and so on.

They have the hospital batch in NY I believe then the VA hospitals. So, that should be a lot of revenue over the next year just out of Excellagen. That's a revenue stream that they implied would be coming in. So, where is the news on it?